Litcius/Paper detail

Co‐reactivation of the human herpesvirus alpha subfamily (herpes simplex virus‐1 and varicella zoster virus) in a critically ill patient with COVID‐19

Rui Xu, Yujie Zhou, Lihua Cai, L. Wang, Jian-Bao Han, Xiaoyun Yang, Jinjun Chen, Jinjun Chen, Charlie Ma, Li-Ling Shen

2020British Journal of Dermatology100 citationsDOIOpen Access PDF

Abstract

namely 10% and 34%, respectively in 1988, compared with 5% and 28% (if seborrhoea is included) or 18% (for eczema excluding seborrhoea). The differences might indicate a lower threshold for referral or an actual increase in disease prevalence.

Topics & Concepts

MedicineDermatologySkin cancerReferralIncidence (geometry)CancerDemographyPediatricsFamily medicineInternal medicineSociologyOpticsPhysicsDermatological and COVID-19 studiesHerpesvirus Infections and TreatmentsSARS-CoV-2 and COVID-19 Research
Co‐reactivation of the human herpesvirus alpha subfamily (herpes simplex virus‐1 and varicella zoster virus) in a critically ill patient with COVID‐19 | Litcius